Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. Campbell is active.

Publication


Featured researches published by E. Campbell.


Urology | 1994

Loin pain-hematuria syndrome: Howeffective is renal autotransplantation in its treatment?

John Harney; Eamon Rodgers; E. Campbell; David P. Hickey

OBJECTIVESnTo evaluate our experience with renal autotransplantation in the management of loin pain-hematuria (LPH) syndrome after relatively long follow-up (30 to 35 months).nnnMETHODSnFour patients with LPH syndrome of 3 to 18 years duration underwent technically successful autotransplantation. All patients preoperatively had normal radiologic investigations, including renal arteriography and biopsy. All required narcotic analgesia for pain control. Patients were followed for 30 to 35 months.nnnRESULTSnAll 4 patients were pain and narcotic free for 6 months postoperatively. At 18 months after surgery, 3 of the 4 had recurrence of the pain and at 30 months, 2 required nephrectomy. Only 1 patient of 4 had sustained pain relief at 35 months.nnnCONCLUSIONSnRenal autotransplantation certainly offers temporary relief from LPH syndrome, but in our experience this was not durable in the majority of our patients.


Irish Journal of Medical Science | 1990

Clinical and histopathologic findings in adults with the nephrotic syndrome.

W. Medawar; Andrew Green; E. Campbell; M. Carmody; J. Donohoe; G. Doyle; J. J. Walshe

SummaryThe clinical and histopathologic findings in 225 Irish adults with nephrotic syndrome were reviewed. Membranous nephropathy was the most common lesion found (28%), followed by proliferative glomerulonephritis (17%), and focal sclerosing glomerulonephritis (16%). Minimal change disease was the least frequent cause for idiopathic nephrotic syndrome (12%). The major secondary cause of nephrotic syndrome was amyloidosis (13%). The patients were analysed for the predictive value of the level of renal function, presence or absence of hypertension, and the degree of proteinuria. It was not possible to determine the nature of the underlying lesion giving rise to the nephrotic syndrome using any of these variables. There was also no significant difference between primary and secondary glomerular disease with regard to these factors. It is concluded that renal biopsy remains the only definitive method of establishing the underlying lesion causing idiopathic nephrotic syndrome.


American Journal of Kidney Diseases | 1997

Light chain deposition disease complicating familial mediterranean fever

John P. Vella; G.D. Doyle; E. Campbell; J. J. Walshe

Familial Mediterranean fever (fMf) is an inherited condition characterized by polyserositis and is sometimes complicated by AA renal amyloidosis leading to nephrotic syndrome and renal failure. We present a case of a man with fMf who presented with rapidly progressive renal failure caused by light chain deposition disease. This disease association has not previously been described in the medical literature.


Irish Journal of Medical Science | 1983

Phenylbutazone nephrotoxicity — A light and electron microscopic study

G. Doyle; E. Campbell; N. Gavin; P. Garrett; M. Carmody

SummaryThis report concerns a young man who developed jaundice and anuria following ingestion of phenylbutazone. In addition to light microscopical findings, details of the ultrastructural changes in the kidney are described.


Nephrology Dialysis Transplantation | 2004

Acute interstitial nephritis: clinical features and response to corticosteroid therapy

Michael R. Clarkson; Louise Giblin; Fionnuala P. O'Connell; Patrick O'Kelly; J. J. Walshe; Peter J. Conlon; Yvonne M. O'Meara; Anthony Dormon; E. Campbell; John Donohoe


Kidney International | 2006

Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk

Mark A. Little; Peter J. Dupont; E. Campbell; Anthony Dorman; J. J. Walshe


Nephrology Dialysis Transplantation | 1989

Recurrent Glomerulonephritis in Renal Transplants: Fourteen Years' Experience

Yvonne M. O'Meara; Andrew Green; M. Carmody; John Donohoe; E. Campbell; O. Browne; J. J. Walshe


American Journal of Kidney Diseases | 2002

Familial membranoproliferative glomerulonephritis type III

John Neary; Anthony Dorman; E. Campbell; Mary Keogan; Peter J. Conlon


Nephrology Dialysis Transplantation | 1990

Successful treatment with cyclosporin of nephrotic syndrome due to focal segmental glomerulosclerosis recurring in a renal transplant.

Andrew Green; Yvonne M. O'Meara; E. Campbell; M. Carmody; John Donohoe


Kidney International | 2006

Response to ‘Differences between type I and II membranoproliferative glomerulonephritis’

Mark A. Little; Peter J. Dupont; E. Campbell; A. Dorman; J. J. Walshe

Collaboration


Dive into the E. Campbell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Green

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge